Novare Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $215K | Sell |
|
|||||
|
2024
Q4 | $228K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $258K | Sell |
|
|||||
|
2023
Q4 | $306K | Sell |
|
|||||
|
2023
Q3 | $439K | Sell |
|
|||||
|
2023
Q2 | $766K | Sell |
|
|||||
|
2023
Q1 | $1.04M | Buy |
|
|||||
|
2022
Q4 | $1.3M | Buy |
|
|||||
|
2022
Q3 | $934K | Sell |
|
|||||
|
2022
Q2 | $1.14M | Buy |
|
|||||
|
2022
Q1 | $901K | Sell |
|
|||||
|
2021
Q4 | $1.46M | Buy |
|
|||||
|
2021
Q3 | $252K | Buy |
|
|||||
|
2021
Q2 | $216K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $207K | Sell |
|
|||||
|
2020
Q3 | $226K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $246K | Buy |
|
|||||
|
2019
Q4 | $203K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $202K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $7.08M | Buy |
|
|||||
|
2017
Q1 | $7.01M | Buy |
|
|||||
|
2016
Q4 | $6.63M | Buy |
|
|||||
|
2016
Q3 | $6.68M | Sell |
|
|||||
|
2016
Q2 | $7.07M | Buy |
|
|||||
|
2016
Q1 | $5.75M | Sell |
|
|||||
|
2015
Q4 | $6.59M | Buy |
|
|||||
|
2015
Q3 | $6.37M | Buy |
|
|||||
|
2015
Q2 | $6.21M | Buy |
|
|||||
|
2015
Q1 | $6.24M | Buy |
|
|||||
|
2014
Q4 | $5.45M | Buy |
|
|||||
|
2014
Q3 | $241K | Buy |
|
|||||
|
2014
Q2 | $235K | Buy |
|
|||||
|
2014
Q1 | $239K | Sell |
|
|||||
|
2013
Q4 | $320K | Sell |
|
|||||
|
2013
Q3 | $398K | Buy |
|
|||||
|
2013
Q2 | $366K | Buy |
|